Table 7.
Logistic regression to analyze the effect of variables for those who selected yes for the question “Did you reduce or discontinue the use of other pharmacologic treatment modalities?”
| Variable | OR | 95% CI | P value |
|---|---|---|---|
| Type of arthritis | |||
| Osteoarthritis | Ref. | ||
| Other autoimmune arthritis | 1.19 | 0.53–2.66 | 0.679 |
| Rheumatoid arthritis | 0.63 | 0.35–1.12 | 0.116 |
| Frequency of CBD use | |||
| < Once a month | Ref. | ||
| Once a month | 4.15 | 0.83–20.83 | 0.084 |
| Once a week | 2.46 | 0.62–9.74 | 0.199 |
| Once a day | 5.98 | 1.68–21.32 | 0.006* |
| More than once a day | 16.91 | 4.63–61.72 | <0.001* |
| Duration of CBD use | |||
| Less than 30 days | Ref. | ||
| 1–6 months | 1.18 | 0.50–2.75 | 0.71 |
| 6 months–1 year | 2.42 | 0.96–6.10 | 0.061 |
| 1–3 years | 2.38 | 0.99–5.68 | 0.052 |
| >3 years | 3.61 | 1.22–10.69 | 0.020* |
Logistical regression model controlled for age, gender, and ethnicity as covariates
CBD cannabidiol, OR odds ratio, CI confidence interval, % percent, Ref. reference
*Statistically significant (P < 0.05)